Climb Bio, Inc. (NASDAQ:CLYM) IPO

Climb Bio, Inc.

IPO

Went public as Eliem Therapeutics, Inc. Priced at US$12.50 a share on Aug 9, 2021.

Price
US$12.50 a share
Shares offered
6,400,000 shares of common stock
Offering size
US$80 million
Underwriters' option
Up to 960,000 more shares
Underwriters
SVB Leerink, Evercore ISI, Stifel, Guggenheim Securities · In the order on the cover

Steps

StepWhen
Draft sent to the SEC in confidenceMay 12, 2021
Filed publiclyJul 16, 2021
Amended 4 timesNewest Aug 9, 2021
Shares registered with an exchangeAug 3, 2021
Declared effective by the SECAug 9, 2021
Final prospectus, with the priceAug 11, 2021

From the cover of the final prospectus (424B4) filed Aug 11, 2021